- Tel: 858.663.9055
-
Email: info@nsjbio.com
- Tel: 858.663.9055
- Email: info@nsjbio.com
Related Products
|
Recombinant Cytokeratin 19 antibody is a reagent for detecting cytokeratin 19, a type I intermediate filament protein encoded by the KRT19 gene. Cytokeratin 19 is widely expressed in epithelial tissues and is distinguished as the smallest keratin without a partner type II keratin. Its expression marks epithelial cells and certain progenitor populations, making it an important tool in cell biology and cancer research.
Cytokeratin 19 contributes to the cytoskeletal network that provides mechanical stability and resilience to epithelial cells. It also participates in signaling pathways that regulate proliferation, differentiation, and tissue organization. Because of its widespread expression in simple epithelia, cytokeratin 19 is a commonly used marker in pathology to define epithelial origin of tumors.
The Recombinant Cytokeratin 19 antibody clone rKRT19/799 provides accurate and consistent detection. Recombinant production guarantees lot to lot uniformity, reducing variability in experimental results. Clone rKRT19/799 has been widely applied in oncology to evaluate carcinoma origin, in stem cell biology to track progenitor cells, and in regenerative medicine to study epithelial differentiation. Its versatility makes it valuable across research fields.
Research using clone rKRT19/799 has revealed how cytokeratin 19 expression informs cancer classification and prognosis. Elevated levels of cytokeratin 19 fragments in serum serve as biomarkers in lung and gastrointestinal cancers. Beyond oncology, cytokeratin 19 detection aids in mapping epithelial lineages during development and tissue repair. The antibody supports both basic and translational research applications.
NSJ Bioreagents offers this Recombinant Cytokeratin 19 antibody to support studies of epithelial biology and cancer. The protein is also known as KRT19 antibody, CK19 antibody, keratin 19 antibody, and cytoskeletal intermediate filament protein antibody, reflecting the varied terminology found in the literature.
Optimal dilution of the recombinant Cytokeratin 19 antibody should be determined by the researcher.
1. The prediluted format is supplied in a dropper bottle and is optimized for use in IHC. After epitope retrieval step (if required), drip mAb solution onto the tissue section and incubate at RT for 30 min.
Recombinant human KRT19 protein was used as the immunogen for the recombinant Cytokeratin 19 antibody.
Store the recombinant Cytokeratin 19 antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).
Your bulk quote request has been submitted successfully!
Please contact us if you have any questions.